刚果东部正经历历史上传播速度最快的埃博拉疫情。截至最近统计，疫情已造成999至1031人死亡[1][2]，确诊病例超过2473例[1]。
这次疫情由罕见的Bundibugyo病毒引发[1][2]，于5月15日宣布[1]。该病毒株目前缺乏已批准的疫苗或治疗手段[1]。伊图里省成为疫情中心，占近90%的病例[2]，另有四个省份也出现了确诊病例[1]。
疫情防控面临严峻挑战。医疗中心工作人员因数周的危险工作与缺乏报酬而罢工[2]，目前有737名患者正在隔离和医院接受治疗[1]。令人担忧的是，新增病例中有80%来自未知的传播链[1]。
相比之下，2013至2016年的西非埃博拉疫情造成超过11000人死亡、至少28000例病例[1]。非洲疾病防控中心主任Jean Kaseya警告称："如果我们今天不阻止这次疫情，它可能成为世界有史以来最严重的埃博拉疫情之一"[1]。
为应对疫情，研究人员已启动治疗试验，测试吉利德公司的remdesivir和Mapp生物制药公司的MBP134两种可能的治疗方案[2]。世卫组织警告称，可能需要数月时间和多达1000名研究参与者才能确定这些药物的有效性[2]。
A Bundibugyo virus outbreak in eastern Congo has emerged as the fastest-growing Ebola epidemic on record, with confirmed deaths exceeding 1,000 people and more than 2,400 confirmed cases as of Monday [1][2]. The disease, declared a public health emergency on May 15, is spreading at an unprecedented pace compared to the 2013-2016 West African outbreak, which killed over 11,000 people [1].
The epidemic centers primarily in Ituri Province, accounting for nearly 90 percent of cases, though infections have been confirmed across five provinces [2]. Among the 2,473 confirmed cases reported, 737 patients are currently isolated and receiving treatment in hospitals [1]. A significant challenge confronting response efforts is that approximately 80 percent of new cases stem from unknown transmission chains, complicating containment efforts [1].
The Bundibugyo virus strain presents particular difficulties because no approved vaccine or treatment exists [1]. In response, researchers have launched clinical trials testing remdesivir, developed by Gilead Sciences, and MBP134, created by Mapp Biopharmaceutical, as potential therapeutic interventions [2]. The World Health Organization has cautioned that determining the drugs' effectiveness could require several months and involve up to 1,000 research participants [2].
Response operations face mounting obstacles. Healthcare workers have staged strikes due to weeks of hazardous work without compensation [1][2]. Armed conflict, limited infrastructure in remote areas, and community mistrust further impede outbreak control efforts [2].
The situation carries severe potential consequences. Jean Kaseya, director of the African Centers for Disease Control and Prevention, stated: "If we don't stop this outbreak today, it may become one of the worst Ebola outbreaks in the history of the world" [1]. In a worst-case scenario, deaths could approach levels seen during the 2014-2016 West African epidemic [2]. This marks Congo's 17th known Ebola outbreak [2].